AwesomeCapital: Biogen: Oppenheimer & Co cut the target on Biogen Inc. to $290 from $360.

Tuesday, August 8, 2023

Biogen: Oppenheimer & Co cut the target on Biogen Inc. to $290 from $360.

Maintains outperform rating.

https://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)